TherapeuticsMD
TXMD
TXMD
134 hedge funds and large institutions have $867M invested in TherapeuticsMD in 2017 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
+17
Holders Change %
+14.53%
% of All Funds
3.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
43
Reduced
40
Closed
8
Calls
$1.89M
Puts
$2.27M
Net Calls
-$374K
Net Calls Change
-$3.17M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$32.5M |
| 2 |
Bank of New York Mellon
New York
|
+$15.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.9M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.83M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.59M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$23.2M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$3.95M |
| 3 |
State Street
Boston,
Massachusetts
|
-$3.44M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$2.98M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.56M |
